0.1985SEK+11.20%Mkt Cap: 2.95M $P/E: —1d ago
Prostatype Genomics AB (publ) manufactures, markets, and sells prognostic gene tests. The company offers a Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, glea…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap2.95M $
Enterprise Value763.41K $
Revenue (TTM)56.82K $
Gross Profit56.82K $
Net Income (TTM)-4.26M $
Revenue/Share0.0017 USD
Last Price0.1985 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees7
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.99
PEG—
EV/EBITDA-0.22
EV/Revenue13.44
P/S51.99
P/B0.44
EPS (TTM)-0.50
EPS (Forward)-0.10
52W Range
0.14053% of range2.280
52W High2.280 SEK
52W Low0.1405 SEK
Profitability
Gross Margin100.00%
Oper. Margin-5423.28%
EBITDA Margin0.00%
Profit Margin-7492.09%
ROE-167.75%
ROA-87.50%
Growth
Revenue Growth-25.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.28M $
CapEx (TTM)1.29M $
FCF Margin-4236.81%
FCF Yield-81.50%
Net Debt-360.42K $
Net Debt/EBITDA0.10
Balance Sheet
Debt/Equity0.20
Current Ratio0.44
Quick Ratio0.40
Book Value/Sh0.4480 SEK
Cash/Share0.1530 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateOct 31, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.155.57M
Float40.52M
Insiders28.84%
Institutions0.00%
Technical
SMA 500.4425 (-55.1%)
SMA 2000.7509 (-73.6%)
Beta1.49
S&P 52W Chg19.63%
Avg Vol (30d)959.39K
Avg Vol (10d)2.26M
Technical Indicators
RSI (14)36.5
MACD-0.0907
MACD Signal-0.0788
MACD Hist.-0.0119
BB Upper0.6360 SEK
BB Middle0.3501 SEK
BB Lower0.0642 SEK
BB Width163.31%
ATR (14)0.1316 SEK
Vol Ratio (20d)0.71x